Talar Derashodian retweeted
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial out in @EUplatinum
sciencedirect.com/science/ar…
The PACE-A trial is a phase 3⃣ randomized study comparing patient-reported outcomes between stereotactic body radiotherapy☢️ (SBRT) and prostatectomy in men with low- to intermediate-risk localized #ProstateCancer
It assessed health-related quality of life, focusing on urinary incontinence, bowel function, and sexual health two years after treatment.
Results showed that SBRT led to significantly less urinary incontinence and better sexual function, while prostatectomy resulted in better bowel scores.
However, SBRT was associated with slightly more bowel issues. These findings provide important insights for treatment decisions in localized prostate cancer.
@nickva1
@royalmarsdenNHS
@alison_tree
@DrTolan
@EmmaHall71
Talar Derashodian retweeted
Replying to @GertMeerleer
@GertMeerleer reminds us that Moses was given a 11th commandment in Mount Sinaï.. Luckily, 3500 years later, @_ShankarSiva and other #rccsbrt prophets disobeyed and proved that radiotherapy could cure localized RCC patients. @GFRU_RO #GFRU24 #renalcancer #FastrackII
Talar Derashodian retweeted
#Curietherapies2023 in underway with a great talk on guiding principles for a new program implantation
Talar Derashodian retweeted
Thank you for 20 years of Leadership and Support #HimuLukka #GUROC22
And welcome to the new co-chairs Scott Morgan @niazi_Dr7
Talar Derashodian retweeted
Happy to share our @CleClinicUro findings: high risk Decipher scores are associated with the presence of Cribriform either alone or in combination with Intraductal Carcinoma features at RP. authors.elsevier.com/a/1fA8y…
Talar Derashodian retweeted
Yujing @yujingzou and Fabian @Naib4f enjoying themselves at the @curietherapies! Future of #brachytherapy is bright!
#curietherapies2022 @McGillMedPhys
#Thisisbrachytherapy
A great conclusin to a great meeting with Dr Cynthia Menard discussing focal prostate brachytherapy @curietherapies #Curietherapies2022
2
Talar Derashodian retweeted
Dr Marjory Jolicoeur @jolicom shared her experience of 2-fractions in one day HDR monotherapy for prostate cancer. #curietherapies2022 #brachytherapy
Talar Derashodian retweeted
Will Dr Morton give the answer to this eternal debate? Is biochemical failure in prostate cancer a surrogate endpoint for survival?#curietherapies2022 #brachytherapy
Josh Yamada and @stef_corradini discussing ways to move brachytherapy forward! #Curietherapies2022 #brachytherapy
Talar Derashodian retweeted
Very interesting! Brachytherapy for bone metastasis talk delivered by Dr Josh Yamaha #curietherapies2022
Talar Derashodian retweeted
Great talk ongoing by Dr Peter Hoskin on oesophageal and bronchus brachytherapy! #Curietherapies2022 #brachytherapy
Talar Derashodian retweeted
The third day started with Dr Phillip Develin talkin about skin brachytherapy. #curietherapies2022
Talar Derashodian retweeted
Dr Fleur Huang started the day early with a presentation on cervix brachytherapy and the EMBRACE studies #curietherapies2022 #brachytherapy
Talar Derashodian retweeted
First part of the hands-on breast implant workshop is a success. Second part scheduled today! #Curietherapies2022
Talar Derashodian retweeted
How to attract trainees in brachytherapy? What an excellent talk by @DrMarkCorkum @curietherapies! #Thisisbrachytherapy #Curietherapies2022
Talar Derashodian retweeted
Ongoing case discussions about 2nd breast conservation therapy. #Curietherapies2002 #brachytherapy
Talar Derashodian retweeted
Spring in Montréal = @curietherapies. Blossoming tree seen this morning while walking to the Congress.
It great to see colleagues and friends at the Curietherapies 10th annyversary meeting! #Curietherapies2022 #brachytherapy





























